Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults

International Journal of Cardiology

Volumn 162, Issue 3, 2013, Pages 240-244

  Thayer, Julian F ^a,b   Fischer, Joachim E ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Arteriosclerosis; Autonomic; Cholesterol; Heart rate variability; Nervous system; Norepinephrine

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NORADRENALIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORADRENALIN URINE LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; ADRENERGIC SYSTEM; AIRCRAFT; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; CONTROLLED STUDY; EMPLOYEE; GERMANY; HEART BEAT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MANUFACTURING INDUSTRY; NEUROMODULATION; SERUM;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHOLESTEROL; CIRCADIAN RHYTHM; FEMALE; HEALTH STATUS; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; YOUNG ADULT;

EID: 84872495509     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.058     Document Type: Article

References (31)

1. J.F. Thayer, S.S. Yamamoto, and J.F. Brosschot The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors Int J Cardiol 141 2 2010 122 131
2. H. Molgaard, K.E. Sorensen, and P. Bjerregaard Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death Clin Auton Res 1 3 1991 233 237
3. M. Kornitzer Predictive value of electrocardiographic markers for autonomic nervous system dysfunction in healthy populations: more studies needed Eur Heart J 22 2 2001 109 112
4. Health NIo national cholesterol education program. second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II) Circulation 89 3 1994 1333 1445
5. G.P. Puschel Control of hepatocyte metabolism by sympathetic and parasympathetic hepatic nerves Anat Rec A Discov Mol Cell Evol Biol 280 1 2004 854 867
6. K.I. Shanygina, M.P. Fomina, N.S. Parfenova, and N.M. Kalashnikova Changes in the cholesterol metabolism of rats following sympathetic and parasympathetic denervation of the liver Vopr Med Khim 27 4 1981 505 509
7. J.H. Christensen, E. Toft, M.S. Christensen, and E.B. Schmidt Heart rate variability and plasma lipids in men with and without ischaemic heart disease Atherosclerosis 145 1 1999 181 186
8. M. Kupari, J. Virolainen, P. Koskinen, and M.J. Tikkanen Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample Am J Cardiol 72 12 1993 897 903
9. K.H. Greiser, A. Kluttig, and B. Schumann Cardiovascular diseases, risk factors, and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006 Eur J Epidemiol 24 2009 123 142
10. J.F. Thayer, S.S. Yamamoto, and J.F. Brosschot On the nature of risk factors: a response to Kluttig, Kuss, and Greiser Int J Cardiol 145 2010 560 561
11. Cholesterol Treatment Trialists Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
12. I.R. White, E.J. Brunner, and J.L. Barron A comparison of overnight and 24 hour collection to measure urinary catecholamines J Clin Epidemiol 48 2 1995 263 267
13. J.E. Dimsdale, T. Coy, M.G. Ziegler, S. Ancoli-Israel, and J. Clausen The effect of sleep apnea on plasma and urinary catecholamines Sleep 18 5 1995 377 381
14. J.E. Dimsdale, and M.G. Ziegler What do plasma and urinary measures of catecholamines tell us about human response to stressors Circulation 83(Suppl. 4 1991 II36 II42
15. Task Force Guidelines Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Circulation 93(5 1996 1043 1065
16. J. Penttila, A. Helminen, and T. Jartti Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns Clin Physiol 21 3 2001 365 376
17. J.J. Sollers 3rd, T.W. Buchanan, S.M. Mowrer, L.K. Hill, and J.F. Thayer Comparison of the ratio of the standard deviation of the R-R interval and the root mean squared successive differences (SD/rMSSD) to the low frequency-to-high frequency (LF/HF) ratio in a patient population and normal healthy controls Biomed Sci Instrum 43 2007 158 163
18. R.H. Knopp, P. Paramsothy, B. Atkinson, and A. Dowdy Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia Eur Heart J 24 2003 729 741
19. R.M. Law, N.J. Wald, and S.G. Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 308 1994 367 373
20. J.P. Saul Beat-to beat variations of heart rate reflect modulation of cardiac autonomic outflow News Physiol Sci 5 1990 32 37
21. Fagundes CP, Murray DM, Hwang GS, Gouin JP, Thayer JF, Sollers III JJ, Shapiro CL, Malarkey WB, Kiecolt-Glaser JK, in press Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology.
22. M. Vlcek, Z. Radikova, A. Penesova, R. Kvetnansky, and R. Imrich Heart rate variability and catecholamines during hypoglycemia and orthostasis Auton Neurosci 143 2008 53 57
23. G. Grassi Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives Hypertension 54 2009 690 697
24. A. Penesova, Z. Radikova, and E. Cizmarova The role of norepinephrine and insulin resistance in an early stage of hypertension Ann N Y Acad Sci 1142 2008 490 494
25. J. Lewandowski, M. Sinski, and J. Bidiuk Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia Hypertens Res 33 2010 1038 1043
26. S.F. Morrison Differential control of sympathetic outflow Am J Physiol Regul Integr Comp Physiol 281 2001 R683 R689
27. L.M. Scott, and G.H. Tomkin Cholesterol metabolism: regulatory effects of the vagus in the normal and diabetic animal Diabetes Res 2 6 1985 313 317
28. H.J. Kissler, J. Hauffen, R. Hennig, H. Gepp, and P.O. Schwille Glucose and lipid metabolism after liver transplantation in inbred rats: consequences of hepatic denervation Metabolism 54 7 2005 881 890
29. A.N. Pehlivanidis, V.G. Athyros, D.S. Demitriadis, A.A. Papageorgiou, V.J. Bouloukos, and A.G. Kontopoulos Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease Atherosclerosis 157 2001 463 469
30. C.M. Welzig, D.G. Shin, H.J. Park, Y.J. Kim, J.P. Saul, and J.B. Galper Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: G alpha(i2), a possible molecular marker for parasympathetic responsiveness Circulation 108 22 2003 2743 2746
31. P. Palatini, D. Longo, V. Zaetta, D. Perkovic, R. Garbelotto, and A.C. Pessina Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity J Hypertens 24 7 2006 1375 1381